New Center for Biomedical Technology

Stewart Bros. Photographers, Inc. Future site of the HHMI's collaborative research campus. New laboratories will be located in the lower left; the institute will occupy portions of the three office buildings pictured to the right. The Howard Hughes Medical Institute, the nation's largest privately held funder of biomedical research, has announced plans to build a major new high-tech laboratory facility. The 10-year, $500 million plan includes a biomedical science center for technology developme

Written byEugene Russo
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Stewart Bros. Photographers, Inc.

Future site of the HHMI's collaborative research campus. New laboratories will be located in the lower left; the institute will occupy portions of the three office buildings pictured to the right.
The Howard Hughes Medical Institute, the nation's largest privately held funder of biomedical research, has announced plans to build a major new high-tech laboratory facility. The 10-year, $500 million plan includes a biomedical science center for technology development complete with on-site housing and labs for 200 to 300 staff members--approximately 24 investigators and their research staffs. Construction will begin in early 2003 and the facility should be completed by mid-2005.

Late last year, HHMI, which is headquartered in Chevy Chase, Md., purchased 281 acres of farmland located in nearby Loudoun County, Va., outside Washington, D.C., for $53.7 million. The planned center will be HHMI's first "in-house" facility owned and operated entirely by HHMI; the institute ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies